Author: PWeekly

Most patients with neurovascular age-related macular degeneration (nAMD) would not qualify for the trials that inform currents standards of care, according to a study presented at the 39th Annual Scientific Meeting of ASRS 2021...

Only one-third of Medicare beneficiaries with neovascular age-related macular degeneration (nAMB) were “persistent” with anti-VEGF monotherapy treatment each year, according to a study presented at the 39th Annual Scientific...

Geographic disparities in access to clinical trial sites exist for neovascular age-related macular degeneration (nAMD) in the United States, according to a study presented at the 38th Annual Scientific Meeting of the American...

Investigators sought to assess the impact of telerehabilitation in patients with MS during the isolation period of the COVID-19 pandemic. They conducted a retrospective analysis using medical records from adults with MS and...

Data presented at prior CMSC meetings described baseline, 1-year, and 2-year results of the Multiple Sclerosis Achievement Center, which assessed day wellness programs targeting physical, cognitive, and social well-being in...

The lack of behavioral interventions that aim to increase physical activity (PA) among individuals with fatigue prompted researchers to examine variables of social cognitive theory (SCT) as correlates of PA among adult patients...

Research demonstrates that Black Americans with MS experience more aggressive disease and a higher lesion burden when compared with White Americans, but the factors associated with these disparities have not been examined. To...

While COVID-19 vaccines are recommended for people with neuromyelitis optica spectrum disorder (NMOSD) and MOG-antibody-associated disease (MOGAD), they were not specifically tested in this population, and thus, have an unclear...